Increase of Macrolide-Resistance in Streptococcus pneumoniae Strains After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Lima, Peru

Increase of Macrolide-Resistance in Streptococcus pneumoniae Strains After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Lima, Peru

Streptococcus pneumoniae upper respiratory infections and pneumonia are often treated with macrolides, but recently macrolide resistance is becoming an increasingly important problem. The 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in the National Immunization Program of Peru in...

Full description

Bibliographic Details
Main Authors: Brayan E. Gonzales, Erik H. Mercado, Maria Pinedo-Bardales, Noemi Hinostroza, Francisco Campos, Eduardo Chaparro, Olguita Del Águila, María E. Castillo, Andrés Saenz, Isabel Reyes, Theresa J. Ochoa
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Streptococcus pneumoniae
macrolide-resistance
invasive pneumococcal disease
pneumococcal conjugate vaccine
healthy carrier
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.866186/full

Similar Items

Similar Items